Last update 23 Jan 2025
Gema Biotech S.A.

Gema Biotech S.A.

Private Company|
1998|
Argentina
|
250-500
|
www.gemabiotech.com

Overview

Basic Info

Introduction
GEMABIOTECH is engaged in the innovation, manufacturing, and distribution of biopharmaceutical products dedicated to human health.

Related

1
Drugs associated with Gema Biotech S.A.
Follitropin alfa biosimilar(Gema Pharma)
Target
FSHR
Mechanism
FSHR agonists
Active Org.-
Originator Org.
Gema Pharma
Active Indication-
Inactive Indication
Infertility
Drug Highest PhasePending
First Approval Ctry. / Loc.-
First Approval Date-
4
Clinical Trials associated with Gema Biotech S.A.
NCT03403140
/ Unknown statusPhase 3
Multicenter Extension Study To 104 Weeks To Asses The Efficacy, Safety And Immunogenicity Of Enerceptan® In Combination With Methotrexate For The Treatment Of Patients With Rheumatoid Arthritis
NCT03332719
/ CompletedPhase 3
Multicentric Evaluator-blinded Randomized Non-inferiority Study, to Asses the Compared Efficacy, Safety and Immunogenicity of Enerceptan® With Enbrel® in Combination With Methotrexate for the Treatment of Patients With Rheumatoid Arthritis
NCT03404752
/ Unknown statusPhase 3
A Randomized, Multicenter Clinical Trial to Determine the Efficacy, Safety and Tolerability of Peg-filgrastim (Gema) Compared to Peg-filgrastim (Roche) for Prevention of Chemotherapy Induced Neutropenia in Patients With Breast Cancer
100 Clinical Results associated with Gema Biotech S.A.
Login to view more data
0 Patents (Medical) associated with Gema Biotech S.A.
Login to view more data
100 Deals associated with Gema Biotech S.A.
Login to view more data
100 Translational Medicine associated with Gema Biotech S.A.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Follitropin alfa biosimilar(Gema Pharma)
 ( FSHR )		Infertility
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free